Product Information
FLUOXETINE HCL 60 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1817 per EA under NDC 16714011401. Its NADAC has been published 344 times since Mar 4, 2020.
FDA first approved this application on Jan 25, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714011401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL; ORAL
Effective Date
9/23/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211721FDA Approved
1/25/2019
TE Code
AB
On Market Since
9/18/2019
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 60 MG TABLET has been published 344 times since Mar 4, 2020, and over the history we have for it it has declined 94.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1817 per EA |
|---|---|
| All-time high | $3.5156 (Jul 15, 2020) |
| All-time low | $0.1817 (Sep 23, 2026) |
| 52-week high | $0.4087 |
| 52-week low | $0.1817 |
| Median price | $0.5586 |
| Average price | $0.7955 |
| Largest weekly change | -58.4% (Jul 22, 2020) |
| Weeks tracked | 344 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 60 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1817 per EA (NDC 16714011401), effective Sep 30, 2026.
How has the price of FLUOXETINE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 60 MG TABLET has declined 94.7%. It has been tracked across 344 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 60 MG TABLET?
Since Mar 4, 2020, the NADAC for FLUOXETINE HCL 60 MG TABLET has ranged from a low of $0.1817 (Sep 23, 2026) to a high of $3.5156 (Jul 15, 2020), with a median of $0.5586 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 60 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 60 MG TABLET?
FLUOXETINE HCL 60 MG TABLET (NDC 16714011401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.